2025 mBiome Conference will be held as RECOMB-Microbiome 2025.
About RECOMB–Microbiome
The microbiome, comprised of the microbiota, its collective genomes called the metagenome, and myriads of macromolecules and metabolites, is an integral part of the biosphere and our body. Members of the microbiota include bacteria, archaea, microbial eukaryotes, and respective viruses. Recent studies reveal that miniscule constituents of the microbiomes in each environment play pivotal roles in global cycles of energy and elements as well as health and disease of the residing host. Not only are they important in nutrient digestion and gastrointestinal health, but they are also intimately and intricately involved in metabolism, immunity, development, circulation, and behavior, and modulate them in many ways. RECOMB-Microbiome brings together experts in microbiome research to overview enabling technologies and scientific achievements, to discuss challenges and opportunities, and to explore their ecological or biogeochemical impacts and novel pharmabiotics candidates that have potential for maintaining health or treating diseases.
Harvard Medical School and Dana-Farber Cancer Institute
[Highlight] Qi Su*
The Chinese University of Hong Kong
[Highlight] Ki Tae Suk*
Hallym University College of Medicine
[Highlight] Raul Tito Tadeo
KU Leuven
[Highlight] Takuji Yamada*
Tokyo Institute of Technology
[Highlight] Liping Zhao*
Rutgers University
[Paper] Bohao Zou
Hong Kong Baptist University
*Solicited
Programs
Tentative; the final version will include Keynotes, Highlights, Papers, and Lightning talks, as well as Posters.
April 24, Thursday
— Registration/ The Commons, Yonsei University
— Opening/ Centennial Hall, Yonsei University
Keynote 1
Chair: Yong-Sun Bahn (Yonsei University)
— K1. Microbiome data science: Unraveling microbial, viral, and functional diversity — Nikos C. Kyrpides (Joint Genome Institute, Lawrence Berkeley National Laboratory)
10:20–10:35 — Coffee Break
Session 1: Protein and Metabolic Network Analysis in Microbiomes
Chair: Donghyuk Shin (Yonsei University)
— H1. Protein interactions in human pathogens revealed through deep learning — Minkyung Baek (Seoul National University)
— H2. Identification of key metabolic microbiota from the human microbiome and their correlation with health and disease — Che Ok Jeon (Chung-Ang University)
— H3. Metabuli: sensitive and specific metagenomic classification via joint analysis of amino acid and DNA — Jaebeom Kim (Seoul National University)
— P1. Multi-label classification with masked loss for predicting multi-antibiotic resistance in mixed-species MALDI-TOF MS profile — Youngjun Park (Max Planck Institute for Biology of Ageing)
— Lunch / Poster Viewing
— Lightning Talks
Session 2: Core Microbiome and Health Correlations
Chair: Joo-Hong Park (Seoul National University)
— H4. Relational stability for identifying core members in microbiomes — Liping Zhao (Rutgers University)
— H5. Understanding the human microbiome through multi-omics analysis from an ecological perspective — Bong-Soo Kim (Ewha Womans University)
— H6. mi-Mic: a novel multi-layer statistical test for microbiota-disease associations — Yoram Louzoun (Bar-Ilan University)
— H7. Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development — Raul Tito Tadeo (KU Leuven)
15:10–15:30 — Group Photo / Yonsei Campus Tour
15:30–15:45 — Coffee Break
Keynote 2
Chair: Heenam Stanley Kim (Korea University)
— K2. Uncharacterized dark matter in the human microbiome and beyond — Curtis Huttenhower (Harvard University)
Session 3: Metagenomics Data Analysis and Applications
Chair: Sunjae Lee (Gwangju Institute of Science and Technology)
— H8. High-quality genomic catalogs of the human microbiome for the era of microbiome medicine — Insuk Lee (Yonsei University)
— H9. Microbial network inference for longitudinal microbiome studies with LUPINE — Saritha Kodikara (The University of Melbourne)
— P2. Ensemble Expectation-Maximization enables accurate and lightweight taxonomic profiling of long read sequenced metagenomes — Nick Sapoval (Rice University)
— P3. Dynamic contrastive learning with pretrained deep language model enhances metagenome binning for contigs — Bohao Zou (Hong Kong Baptist University)
— K3. Strain and SNV-level resolved microbial genetic diversity in human health and disease — Jingyuan Fu (University Medical Center Groningen)
10:20–10:35 — Coffee Break
Session 4: Computational Tools and Algorithms for Microbiome Analysis
Chair: Jongsik Chun (CJ Bioscience)
— H10. Processing-bias correction with DEBIAS-M and implications for analyzing the microbiome in cancer — Tal Korem (Columbia University)
— H11. Rapid species-level metagenome profiling and containment estimation with sylph — Jim Shaw (Dana-Farber Cancer Institute, Harvard Medical School)
— P4. CAMP: A modular metagenomics analysis system for integrated multi-step data exploration — Lauren Mak (Weill Cornell Medicine)
— P5. Using lossless compression algorithms to improve metagenomics binning and accelerate genome taxonomic classification — Itai Sharon (MIGAL–Galilee Research Institute)
— Lunch / Poster Viewing
— Lightning Talks
Session 5: Environmental Microbiome Responses
Chair: Sukhwan Yoon (Korea Advanced Institute of Science and Technology)
— H12. Viral ecology and evolution in a freshwater lake over three decades — Karthik Anantharaman (University of Wisconsin-Madison)
— H13. Bovine gut microbiome: Effect of castration and fecal microbiota transplantation — Jin-Woo Bae (Kyung Hee University)
— H14. FoodSeq: a genomic biomarker of diet — Lawrence Anthony David (Duke University)
— P6. A shift from heterotrophy to autotrophy underlies microbial adaptation to global desert ecosystems — Pok Man Leung (Monash University)
— P7. Functional regimes define the response of the soil microbiome to environmental change — Kiseok Keith Lee (University of Chicago)
15:25–15:45 — Coffee Break
Session 6: Human Microbiome Studies
Chair: Hong Koh (Yonsei University College of Medicine)
— H15. Gut microbiome report to prognosticate liver diseases — Ki Tae Suk (Hallym University Medical Center)
— H16. Gut microbiota in IBS: Pathogenic insights and FMT-based therapeutics — Qi Su (The Chinese University of Hong Kong)
— H17. Explainable AI (XAI) for gut microbiome-based colorectal cancer classification — Takuji Yamada (Tokyo Institute of Technology)
— P8. Longitudinal oropharyngeal microbial signatures in patients undergoing Allogeneic Hematopoietic Stem Cell Transplantation — Yan Yan (Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences)
Authors will be notified shortly after poster submission.
Tracks
Call for Highlights
RECOMB–Microbiome 2025 invites the submission of abstracts of papers that have been recently published in a journal (mostly during 2024 but not have to be restricted to 2024) or "in press" at the time of submission and are already linked on the journal website. The papers will be selected for oral presentation by taking into consideration the impact of the work on the field, the likelihood that the work will make a good presentation, and the relevance to biological and biomedical research in general. Some highlight talks will be solicited.
Submissions must contain an abstract (including title, author(s), affiliation, e-mail, a link to the published journal version, the identity of the presenter (underlined) followed by the abstract text (about 250 words). In addition to the abstract of the paper, the authors may include a few sentences to explain why the work is suitable for a highlight talk. Please also add the PDF of your full paper as Supplementary. Accepted presenters for the Highlight Track are required to make the presentation themselves and must register for the conference.
Call for Papers
RECOMB–Microbiome 2025 invites submissions that represent original, previously unpublished work. It may include those accepted but not in press for publication in a journal. The committee will rigorously review submitted papers. Selected papers will be accepted for oral presentation at the conference. Accepted papers will be published as proceedings, which will be available at the conference. Authors who prefer not to publish their work in the proceedings, may stand by the originally submitted abstract in lieu of a pages-long paper.
Call for Posters
RECOMB–Microbiome 2025 welcomes the submission of abstracts for the Poster Track that describe primary results. Accepted poster abstracts will be published as submitted in the conference proceedings.
